FYI, Ritu Baral has been pounding that AVNR will get approved; she picked up good credibility with that call. So I hope she comes out with report on MNTA with some good info. on Teva's generic case not holding water.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.